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The safety of thrombolytic therapy of acute myocardial 
infarction could be improved if a method were developed to 
dissolve fresh occlusive coronary thrombus without simul- 
taneously dissolving hemostatic thrombi outside the coro- 
nary arteries. This study is based on the assumption that, in 
a patient with evolving acute myocardial infarction, hemo- 
static thrombi are likely to be older than the thrombus 
responsible for occlusion of the coronary artery. It explored 
whether the relative rates of lysis of fresh and old thrombi 
could be influenced by the rapidity of recombinant tissue- 
type plasminogen activator @t-PA) administration. 
In each of 17 dogs, two 1 h and two 24 h old thrombi 
were produced by inserting copper coils into both jugular 
and both femoral veins. After 24 h and 1 h, respectively, the 
coils with the thrombi were removed, weighed and inserted 
into the adjacent carotid and femoral arteries. A 1 mg/kg 
body weight dose of r&PA was given either over 180 or over 
30 min. The coils were removed and weights of the residual 
thrombi determined at the end of the 180 min infusion 
(Group I), at the end of the 30 min infusion (Group HA) 
and 45 min after the 30 min infusion (Group IIB). The 24 h 
old thrombi were lysed significantly less than the 1 h old 
thrombi in all three experimental groups: 53.9 f 4.8% 
(mean + SE) versus 86.1 + 2.5% in Group I (p < O.OOl), 
16.6 + 3.5% versus 65.2 f 6.0% in Group IIA (p < 0.001) 
and 21.6 + 5.4% versus 91.7 + 1.7% in Group IIB (p < 
0.001). The 24 h old thrombi were also lysed significantly 
less by the 30 min infusion than by the 180 min infusion (p 
< 0.001 for both). The ratio of lysis of 1 and 24 h old 
thrombi was markedly higher in Groups IIA (7.95 + 2.16) 
and IIB (6.52 * 1.50) than in Group I(l.71 * 0.17) (p < 
0.01 for both). 
These findings suggest that r&PA administered rapidly 
over a shorter period is less likely to lyse older thrombus, 
whereas the effect on fresh thrombus is preserved and 
probably enhanced. Clinical studies are needed to confirm 
the conclusions of this experimental study. 
(J Am Co11 Cardiol1989;14:1359-b4) 
It is now generally recognized that thrombolytic therapy of 
acute myocardial infarction restores myocardial perfusion 
(1,2), preserves ventricular function (3-5) and reduces mor- 
tality (6,7). The value of thrombolytic therapy is diminished 
by relatively frequent bleeding, resulting in significant mor- 
bidity and infrequently in death. The risk of serious bleeding 
also leads to exclusion of a great number of patients who 
may otherwise benefit from thrombolytic therapy. 
Bleeding during or early after thrombolytic therapy of 
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acute myocardial infarction has been attributed to lysis of 
hemostatic thrombi protecting defects in the vessel wall 
outside the coronary circulation (8). Hemostatic thrombi 
are likely to be older than the thrombus that caused or 
completed the occlusion of the coronary artery and 
thereby triggered the ongoing acute myocardial infarction. 
If so, the probability of serious bleeding could be reduced 
by a method that would allow lysing fresh coronary 
thrombus without lysing older hemostatic thrombi. In 
this study, we explored whether the relative rates of lysis 
of fresh and old thrombi could be influenced by the rapidity 
of recombinant tissue-type plasminogen activator @-PA) 
administration. 
Methods 
The animals used in this study were maintained in accor- 
dance with the guidelines of the Committee of Laboratory 
Animal Resources of the Cedars-Sinai Medical Center and 
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those prepared by the Committee on Care and Use of 
Laboratory Animals of the Institute of Laboratory Animal 
Resources of the National Institutes of Health. 
Experimental thrombus production. The study was per- 
formed in 17 closed chest mongrel dogs weighing 15 to 32 kg 
(average 23.2) and anesthetized with 30 mg/kg body weight 
of sodium pentobarbital and additional small doses as 
needed to maintain 24 h of stable anesthesia. The dogs were 
intubated and artificially ventilated with use of a Harvard 
respirator. The external jugular and the femoral veins were 
exposed randomly, first on one side and 23 h later on the 
other side. For induction of thrombosis (9), four helically 
shaped copper coils, 25 mm in length and 2 mm in internal 
diameter, were used; they were stripped of their insulation 
and made thrombogenic by brief immersion into sulfuric 
acid. The coils were weighed and then inserted into the 
dissected veins, two initially and two 23 h later. Thrombus 
formation usually began within minutes after insertion of the 
coils. Twenty-four hours after insertion of the first pair of 
coils and 1 h after insertion of the second pair of coils, all 
four coils were retrieved from the veins, weighed again to 
determine the initial weights of thrombi and then inserted 
into the freshly dissected adjacent carotid and femoral 
arteries. The thrombi were solid and firmly adhered to the 
coil. 
A predominantly single chain form of recombinant tissue- 
type plasminogen activator (rt-PA) was administered ac- 
cording to three protocols. (The drug was kindly supplied by 
Genentech Inc.) At the end of the study, the coils were 
removed from the arteries and weighed again to determine 
the weights of the residual thrombi. The degree of lysis was 
expressed as a percent decrease in initial thrombus weight, 
and calculated as the difference between the initial and the 
residual weight divided by the initial weight. An electrocar- 
diographic (ECG) lead and systemic arterial pressure were 
continuously monitored. 
Study protocol. With all four coils in place in the arteries, 
t-t-PA was administered intravenously in a total dose of 1 
mglkg over either 180 or 30 min; 10% of the total dose was 
given as an initial bolus. The 1 mg/kg dose of t-t-PA was 
similar to the dosage applied in human studies (10,l l), 
although not necessarily equivalent in effect. Three groups 
of dogs were studied. 
In Group I Cfive dogs), the 1 mg/kg dose of rt-PA was 
administered over 180 min at a rate of 5 CLglkg/min after an 
initial 100 CLg/kg bolus. The coils were retrieved from the 
arteries, and the degree of lysis was determined immediately 
after the infusion. 
Group II (12 dogs) received the 1 mglkg dose of &PA 
over a period of 30 min at a rate of 30 pg/kg/min after an 
initial 100 pg/kg bolus. In Subgroup IIA (seven dogs), the 
coils were retrieved and the degree of lysis was determined 
immediately after the infusion. In Subgroup IIB (five dogs), 
the coils were removed and the degree of lysis was deter- 
mined 45 min after the end of the infusion, by which time the 
plasma concentration of rt-PA had decreased to ~7% of its 
peak value. 
Plasma concentrations of r&PA. Plasma samples for the 
determination of t-t-PA levels were taken before and at 30, 
120 and 180 min during the infusion in Group I, before and at 
I5 and 30 min during the infusion in Group HA and before 
and at 15 and 30 min during the infusion and at 30 and 45 min 
after the infusion in Group IIB. An enzyme-linked immuno- 
sorbent assay (ELISA) based on monoclonal antibodies was 
used to measure the concentration of rt-PA (12). The analy- 
sis of the rt-PA concentration was performed in the labora- 
tories of the Department of Biochemistry of the University 
of Vermont, College of Medicine. 
Statistical analysis. A general mixed model analysis of 
variance was used to test the effects of thrombus age, length 
of infusion or type of artery on the rate of lysis. This method 
of analysis was chosen to allow for multiple measurements 
within each animal. Pre- to postinfusion changes were as- 
sessed by paired t test. All statistical tests were performed 
with BMDP biostatistical software (13). A p value of <0.05 
was considered to indicate a statistically significant differ- 
ence. All data are presented as mean 2 SEM. 
Results 
Sixty-eight coils were initially implanted in the 17 dogs. 
Eight coils could not be studied (six could not be retrieved 
from the vein and two could not be reinserted into the 
artery). Of these eight coils, two each were in Groups I and 
IIB and four in Group IIA. Thirty 1 h and thirty 24 h old 
thrombi were available for analysis. 
Initial thrombus weight (Table 1). The weight of 1 h old 
thrombi ranged from 81.6 to 193.0 mg (average 143.1 ? 7.0 in 
Group I, 140.0 ? 8.4 in Group IIA and 153.1 ? 7.0 in Group 
IIB). The weight of 24 h old thrombi ranged from 121.6 to 
182.6 mg (average 159.1 ? 4.9 in Group I, 153.5 -t 6.5 in 
Group IIA and 166.8 ? 2.9 in Group IIB). The initial weights 
of 1 and 24 h old thrombi were not significantly different 
among the three groups. There was also no significant 
difference between the weights of 1 and 24 h old thrombi in 
any of the three groups. 
Lysis of thrombi after r&PA (Table 1). The weight of 1 h 
old thrombi decreased by 86.1 ? 2.5% after administration 
of rt-PA over 180 min in Group I, by 65.2 2 6.0% by 
the end of the 30 min infusion in Group IIA and by 91.7 4 
1.7% by 45 min after the end of the 30 min infusion in 
Group IIB. The decrease in Group IIA was significantly 
smaller than that in Group I or Group IIB (p < 0.05 for 
both); this difference was obviously due to removal of 
the coil with the thrombus immediately after the rapid 
infusion when the plasma concentration of rt-PA was still 
very high. 
The weight of 24 h old thrombi decreased by 53.9 2 4.8% 
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% Lysis I h Thrombus 
% Lysis 24 h Thrombus 
Group I (180 min infusion) (n = 5) 
Mean 
tSE 
123.5 12.6 89.8 170.1 64.4 62.1 I .45 
106. I 7.8 92.6 143.5 41.9 70.8 1.31 
146.6 18.4 87.4 156.4 42.5 72.8 I .20 
139.6 15.7 88.8 180.8 68.8 61.9 I .43 
160.0 36.6 77.1 148.0 67.0 54.7 I.41 
1.11.4 5.0 96.2 171.5 93.9 45.2 2.13 
168.6 18.0 89.3 134.9 86.1 36.2 2.47 
169.7 44.9 73.5 163.4 81.8 49.9 1.47 
142.3 28.0 80.3 163.3 112.1 31.4 2.56 
143.1 20.8 86.1 159.1 73.2 53.9 1.71 
1-7.0 k4.4 k2.5 1-4.9 27.7 24.8 20.17 
Group IIA (30 min infusion, no additional exposure) (n = 7) 
Mean 
?SE 
XI.6 38.9 52.3 121.6 79.0 35.0 I .49 
193.0 76.1 60.6 131.9 128.6 2.5 24.24 
162.5 108.0 33.5 169.5 144.9 14.5 2.31 
1’5.7 51.0 59.4 130.9 125.9 3.8 15.63 
138.0 57.8 58.1 182.6 155.9 14.6 3.98 
139.7 6.2 95.6 137.1 126.1 8.0 II.95 
129.5 36.9 71.5 146.9 115.4 21.4 3.34 
109.3 25.5 76.7 157.8 loo.2 36.5 2.10 
174.0 123.2 29.2 131.4 129.2 1.7 17.18 
148.2 35.5 76.0 174.3 150.8 13.5 5.63 
139.6 36.8 73.6 179.0 128.5 28.2 2.61 
139.3 5.2 96.3 179.2 143.9 19.7 4.89 
140.0 50. I 65.2 153.5 127.4 16.6 7.95 
cx.4 ClO.5 26.0 26.5 ~6.3 23.5 22.16 
Group IIB (30 min infusion t 45 min exposure) (n = 5) 
Mean 
+SE 
135.1 17.2 87.3 161.3 124.1 23.1 3.78 
143.5 20.0 86.1 172.2 139.1 19.2 4.48 
112.5 19.0 83.1 162.9 152.1 6.6 12.59 
153.3 7.0 95.4 160.9 150.8 6.3 15.14 
IN.2 3.8 97.7 173.4 141.4 18.5 5.28 
179.7 11.0 93.9 164.4 66.7 59.4 1.58 
174.4 15.0 91.4 179.6 122.6 31.7 2.88 
148.7 4.5 97.0 175.0 149.6 14.5 6.69 
168.9 11.6 93.1 151.5 129.0 14.9 6.25 
153.1 12.1 91.7 166.8 130.6 21.6 6.52 
r7.0 k2.0 kl.7 i2.9 28.8 55.4 21.50 
*Ratio values are calculated as percent lysis of 1 h thrombi divided by percent lysis of 24 h thrombi 
after infusion of rt-PA over 180 min in Group I, by 16.6 ? 
3.5% by the end of the 30 min infusion in Group IIA and by 
21.6 +- 5.4% by 45 min after the end of the 30 min infusion in 
Group IIB. The lysis of 24 h old thrombi was significantly 
greater when the 1 mg/kg dose of rt-PA was infused over 180 
min than after infusion of the same dose over 30 min in 
Group IIA or IIB, both in absolute terms (p < 0.001 for both) 
and relative to lysis of 1 h old thrombi in the same experi- 
ment (Fig. 1). The relation between lysis of 1 and 24 h old 
thrombi in the same experiment is expressed in Table 1 as 
the ratio of lysis of the 1 and 24 h old thrombi from the same 
experiment. The ratio was significantly higher at the end as 
well as 45 min after the 30 min infusion of rt-PA than after its 
infusion over 180 min (p < 0.01 for both). 
Appearance and histologic features of thrombi. Twenty- 
four hour old thrombi appeared darker and had a firmer 
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Figure 1. The differential effect of the rapidity of r&PA administra- 
tion on lysis of fresh and old thrombi. The relations between the 
lysis of 1 and 24 h old thrombi in the three protocol groups. Group 
I = 100 pg/kg bolus of r&PA, followed by 5 pg/kg per min infusion 
for 180 min; Group IIA and IIB = 100 I.Lg/kg bolus of r&PA, followed 
by 30 cLg/kg per min infusion for 30 min. In Group IIA, the degree of 
lysis was determined immediately after the infusion. In Group IIB, 
the degree of lysis was determined 45 min after the infusion. 
consistency than did 1 h old thrombi. For histologic studies, 
thrombi were fixed in formalin, and processed routinely for 
evaluation. Hematoxylin-eosin-stained sections from longi- 
tudinally oriented thrombi were evaluated for the degree of 
separation of blood components into bands of erythrocytes, 
leukocytes and platelets-fibrin (lines of Zahn). In addition, 
fibrin bands were classified as being either dense or loose, on 
the basis of how compact and distinct these bands were in 
relation to other components of the thrombi. Twenty-four 
hour old thrombi tended to have more distinct layering of 
blood components and more compact dense fibrin bands 
than did 1 h old thrombi; however, some overlap of findings 
was observed. 
Plasma levels of r&PA (Table 2). Peak plasma levels were 
about five times higher after the 30 min administration 
compared with the 180 min administration, and rapidly 
decreased after termination of the infusion. 
Discussion 
Effect of tbrombus age on resistance to lysis. In agreement 
with previous experimental (14-17) and clinical studies 
(18,19), older thrombi were more resistant to lysis than 
were fresh thrombi. The increased resistance of older 
thrombi to lysis was present during both rapid and slow 
administration of rt-PA in this study. However, older 
thrombi were lysed to a significantly greater extent when 
the same 1 mg/kg dose of rt-PA was given over 180 rather 
than 30 min. There is no direct evidence to explain why 
older thrombi are lysed more when the rt-PA dose is 
administered more slowly over a longer period of time. 
The explanation may be that older thrombi have a higher 
density (20), due to continuing polymerization and cross- 
linking of fibrin (21-25), and may therefore be less penetrable 
to r&PA and require longer exposure to undergo the same 
degree of lysis. 
Potential clinical implications. Our study assumed that 
hemostatic thrombi that protect vascular defects (in the 
brain, gastrointestinal tract or elsewhere outside the coro- 
nary circulation) are likely to be older than the portion of the 
thrombus that completed the occlusion of the coronary 
artery in a patient with evolving acute myocardial infarction. 
Thus, the finding that rapid administration of t-t-PA appears 
less likely to cause dissolution of older thrombi while main- 
taining and probably enhancing the capacity to lyse fresh 
thrombi could be of great importance if confirmed under 
clinical conditions. A marked reduction in wound bleeding 
coupled with significant enhancement of thrombus lysis was 
observed by Agnelli et al. (26) when rabbits with experimen- 
tal jugular vein thrombosis received a given dose of &PA 
over a shorter period of time. In patients, a decrease in the 
frequency of bleeding complications and an increase in 
infarct-related patency rate of the artery were reported by 
Top01 et al. (27) when the 150 mg dose of r&PA was given 
over 5 rather than 7 h. Administration of a 150 mg dose of 
rt-PA over a period of only 2 h by Lew et al. (28) was 
associated with a low frequency of major bleeding compli- 
cations and a high rate of infarct-related artery patency. 
Thadani (29) observed that prolonged administration of a 
given dose of the double chain form of rt-PA was associated 
Table 2. Plasma Levels of rt-PA (&ml) 
Infusion Time (min) Time After Infusion (min) 
0 15 30 120 180 30 45 
Group I (n = 5) 5k2 563 f 101* 948 r 196* 1,464 ? 364t 
Group IIA (n = 7) 522 5,700 ? 97ti* 7,329 2 1,156$ 
Group IIB (n = 5) 1kO 6,290 ? 1,483t 7,140 c 1,291* 860 2 285t 490 2 202 
*p < 0.01; tp < 0.05; $p c 0.001. Within each group, plasma levels of rt-PA at all time points are compared with pretreatment levels. Data are presented as 
mean + SE. 
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with a significantly increased risk of serious bleeding com- 
plications. 
In light of recent reports (30,31), it may seem that the 
effort to reduce serious bleeding complications and to en- 
hance lysis of coronary thrombus by accelerated administra- 
tion of rt-PA may be in conflict with efforts to prevent 
reocclusion after successful reperfusion of a coronary ar- 
tery. Gold et al. (30) and Johns et al. (31) reported that a 4 h 
maintenance infusion of rt-PA can prevent reocclusion of the 
reopened infarct-related artery. However, because their 
study groups received not only longer infusions of rt-PA but 
also a considerably larger dose of rt-PA administered during 
the maintenance infusion, it cannot be ruled out that the 
lower reocclusion rate was due to the higher total dose of 
rt-PA rather than to the longer infusion. That possibility is 
supported by the finding of Top01 et al. (27) that shortening 
of the duration of infusion of the same dose of rt-PA from 7 
to 5 h resulted, if anything, in a decrease rather than an 
increase in the reocclusion rate. The relatively low 10% early 
reocclusion rate in the study by Lew et al. (28) using a short 
2 h infusion of 150 mg of rt-PA also suggests that it may be 
the higher total dose rather than the protracted administra- 
tion that helps to reduce the rate of reocclusion. Rapid rt-PA 
administration may be both safer, and also appears more 
effective in terms of the frequency and rapidity of coronary 
reperfusion (27). 
It appears, therefore, that accelerated administration of 
rt-PA and possibly other plasminogen activators may im- 
prove both the safety and the efficacy of thrombolytic 
therapy. Clinical investigations are needed to confirm the 
conclusions of this experimental study. 
We thank Dagnija Thornton from the laboratories of the Department of 
Biochemistry, University of Vermont, College of Medicine, Burlington. 
Vermont for the analysis of the &PA plasma concentrations. 
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